login
login

Europe Daily Bulletin No. 13154

1 April 2023
Contents Publication in full By article 18 / 30
EU RESPONSE TO COVID-19 / Health
Bimervax becomes eighth Covid-19 vaccine authorised in EU
Brussels, 31/03/2023 (Agence Europe)

On Thursday 30 March, the European Commission authorised the Covid-19 mRNA vaccine Bimervax developed by HIPRA Human Health S.L.U. (see EUROPE B12922A21) as a booster dose for people aged 16 years and older, who have previously received a Covid-19 mRNA vaccination. 

The vaccine is suitable for both Alpha and Beta variants of SARS-CoV-2.

This authorisation is based on the positive recommendation of the European Medicines Agency (EMA) of 30 March for the approval of the vaccine.

Indeed,...

Contents

SECTORAL POLICIES
EXTERNAL ACTION
SECURITY - DEFENCE
Russian invasion of Ukraine
ECONOMY - FINANCE - BUSINESS
EU RESPONSE TO COVID-19
COURT OF JUSTICE OF THE EU
NEWS BRIEFS